Therapeutic advances in hereditary ATTR amyloidosis

被引:0
|
作者
Hawkins, P. [1 ]
机构
[1] UCL, Royal Free Hosp, Natl Amyloidosis Ctr, London, England
关键词
D O I
10.1016/S0960-8966(18)30292-X
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
S02
引用
收藏
页码:S1 / S1
页数:1
相关论文
共 50 条
  • [1] The Swedish landscape of hereditary ATTR amyloidosis
    Suhr, Ole B.
    Wixner, Jonas
    Pilebro, Bjorn
    Lundgren, Hans-Erik
    Anan, Intissar
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2017, 24 : 93 - 94
  • [2] Heart transplantation in hereditary ATTR amyloidosis
    M Slama
    Orphanet Journal of Rare Diseases, 10 (Suppl 1)
  • [3] Involvement of bile acid in diarrhoea and therapeutic effect of colestimide in hereditary ATTR amyloidosis
    Mochizuki, Yusuke
    Katoh, Nagaaki
    Matsushima, Akira
    Yazaki, Masahide
    Kuwabara, Naoko
    Nakagawa, Saori
    Sekijima, Yoshiki
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2025, 32 (01): : 39 - 45
  • [4] Electrophysiological demyelinating features in hereditary ATTR amyloidosis
    Ohashi, Nobuhiko
    Kodaira, Minori
    Morita, Hiroshi
    Sekijima, Yoshiki
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2019, 26 (01): : 15 - 23
  • [5] Heart Failure in a Patient with hereditary ATTR Amyloidosis
    Reiter, C.
    JOURNAL FUR KARDIOLOGIE, 2020, 27 (3-4): : 109 - 110
  • [6] Current approaches for treatment of hereditary transthyretin amyloidosis (ATTR)
    Zibert, Andree
    Huesing-Kabar, Anna
    Schmidt, Hartmut
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (20) : 1438 - 1443
  • [7] Tafamidis improves bladder function in hereditary ATTR amyloidosis
    Lee, Fang-Ching
    Sakakibara, Ryuji
    Tateno, Fuyuki
    Aiba, Yosuke
    Kishi, Masahiko
    Suzuki, Hiroyoshi
    Shimizu, Ayami
    Takahashi, Osamu
    Takada, Nobuo
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2019, 7 (02): : 81 - 84
  • [8] Hereditary ATTR Amyloidosis: Burden of Illness and Diagnostic Challenges
    Gertz, Morie A.
    AMERICAN JOURNAL OF MANAGED CARE, 2017, 23 (07): : A107 - A112
  • [9] Association between hearing loss and hereditary ATTR amyloidosis
    Bartier, Sophie
    Bodez, Diane
    Kharoubi, Mounira
    Guellich, Aziz
    Canoui-Poitrine, Florence
    Chatelin, Veronique
    Coste, Andre
    Damy, Thibaud
    Bequignon, Emilie
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2019, 26 (04): : 234 - 242
  • [10] Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy
    Paton, D. M.
    DRUGS OF TODAY, 2019, 55 (12) : 727 - 734